diaendoСахарный диабетDiabetes mellitus2072-03512072-0378Endocrinology research centre10.14341/2072-0351-6221diaendo-6221Research ArticleСтатьиArticlesРоль мозгового натрийуретического пептида и его N-концевого предшественника в диагностике хронической сердечной недостаточности и бессимптомной дисфункции левого желудочкапри сахарном диабете 2 типаThe role of brain natriuretic peptide and NT- probrain natriuretic peptide in diagnostics of chronic heart failure and asymptomaticleft ventricular dysfunction in patients with type 2 diabetes mellitusБондарьИрина АркадьевнаBondar'Irina Arkad'evnabondaria@oblmed.nsk.ruГражданкинаДарья ВладимировнаGrazhdankinaDaria Vladimirovna-ГОУ ВПО Новосибирский государственный медицинский университет, НовосибирскNovosibirsk State Medical University, Novosibirsk201115092011143№3 (2011)3135Copyright © Бондарь И.А., Гражданкина Д.В., 20112011Бондарь И.А., Гражданкина Д.В.Bondar' I.A., Grazhdankina D.V.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.dia-endojournals.ru/jour/article/view/6221

В обзоре обобщены данные о мозговом натрийуретическом пептиде (МНП) и N-проМНП, их роли для диагностики хронической сердечнойнедостаточности (ХСН) и бессимптомной дисфункции левого желудочка при сахарном диабете 2 типа.

натрийуретический пептидсердечная недостаточностьсахарный диабетбессимптомная дисфункция левого же- лудочкаnatriuretic peptideheart failurediabetes mellitusasymptomatic left ventricular dysfunctionReferencesМареев В.Ю., Агеев Ф.Т., Арутюнов Г.П., Коротеев А.В., Ревишвили А.Ш. Национальные рекомендации ВНОК и ОССН по диагностике и лечению ХСН (третий пересмотр) // Сердечная недостаточность. - 2010. - № 11(1). - С. 3-62.Мареев В.Ю., Агеев Ф.Т., Арутюнов Г.П., Коротеев А.В., Ревишвили А.Ш. Национальные рекомендации ВНОК и ОССН по диагностике и лечению ХСН (третий пересмотр) // Сердечная недостаточность. - 2010. - № 11(1). - С. 3-62.Kannel W.B., Hjortland M., Castelli W.P. Role of diabetes in congestive heart failure: The Framingham study // Am. J. Cardiol. - 1974. - № 34. - P. 29-34.Kannel W.B., Hjortland M., Castelli W.P. Role of diabetes in congestive heart failure: The Framingham study // Am. J. Cardiol. - 1974. - № 34. - P. 29-34.MacDonald M.R., Petrie M.C., Hawkins N., Petrie J., Fisher M., McKelvie R., Aguilar D., Krum H., Mcmurray J. Diabetes, left ventricular systolic disfunction and chronic heart failure // Eur. Heart. J. - 2008. - № 29. - Р. 1224-1240.MacDonald M.R., Petrie M.C., Hawkins N., Petrie J., Fisher M., McKelvie R., Aguilar D., Krum H., Mcmurray J. Diabetes, left ventricular systolic disfunction and chronic heart failure // Eur. Heart. J. - 2008. - № 29. - Р. 1224-1240.Vaur L., Gueret P., Lievre M., Chabaud S., Passa P. Development of congestive heart failure in type 2 diabetic patients with microalbuminuria or proteinuria: observations from the Diabhycar (type 2 DIABetes Hypertension Cardiovascular Events and Ramipril) study // Diabetes care. - 2003. - № 26. - Р. 855-860.Vaur L., Gueret P., Lievre M., Chabaud S., Passa P. Development of congestive heart failure in type 2 diabetic patients with microalbuminuria or proteinuria: observations from the Diabhycar (type 2 DIABetes Hypertension Cardiovascular Events and Ramipril) study // Diabetes care. - 2003. - № 26. - Р. 855-860.Ватутин Н.Т., Калинкина Н.В., Склянная Е.В., Дубова Т.А., Зима О.О. Натрийуретические пептиды: физиологическая и клиническая роль // Украинский кардиологический журнал. - 2005. - С. 115-121.Ватутин Н.Т., Калинкина Н.В., Склянная Е.В., Дубова Т.А., Зима О.О. Натрийуретические пептиды: физиологическая и клиническая роль // Украинский кардиологический журнал. - 2005. - С. 115-121.Kuhn M. Molecular physiology of natriuretic peptide signaling // Basic. Res. Cardiology. - 2004. - № 99. - Р. 77-78.Kuhn M. Molecular physiology of natriuretic peptide signaling // Basic. Res. Cardiology. - 2004. - № 99. - Р. 77-78.Levin E.R., Gardner D.G., Samson W.K. Natriuretic peptides // N. Eng. J. Med. - 1998. - № 339. - Р. 321-328.Levin E.R., Gardner D.G., Samson W.K. Natriuretic peptides // N. Eng. J. Med. - 1998. - № 339. - Р. 321-328.Mukoyama M., Nakao K., Hosoda K., et al. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide // J. Clin. Invest. - 1991. - № 87. - Р. 1402-1412.Mukoyama M., Nakao K., Hosoda K., et al. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide // J. Clin. Invest. - 1991. - № 87. - Р. 1402-1412.Srisawasdi P., Vanavanan S., Charoenpanichkit C., Kroll M.H. The Effect of Renal Dysfunction on BNP, NT-proBNP, and Their Ratio // Am. J. Clin. Pathol. - 2010. - № 133(1). - Р. 14-23.Srisawasdi P., Vanavanan S., Charoenpanichkit C., Kroll M.H. The Effect of Renal Dysfunction on BNP, NT-proBNP, and Their Ratio // Am. J. Clin. Pathol. - 2010. - № 133(1). - Р. 14-23.Kazanegra R., Cheng V., Garcia A., et al. A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study // J. Card. Fail. - 2001. - № 7. - Р. 21-29.Kazanegra R., Cheng V., Garcia A., et al. A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study // J. Card. Fail. - 2001. - № 7. - Р. 21-29.De Lemos J.A., McGuire D.K., Drazner M.H. B-type natriuretic peptide in cardiovascular disease // The Lancet. - 2003. - № 362. - Р. 316-322.De Lemos J.A., McGuire D.K., Drazner M.H. B-type natriuretic peptide in cardiovascular disease // The Lancet. - 2003. - № 362. - Р. 316-322.Azzazy H.M., Christenson R.H. B-type natriuretic peptide: physiologic role and assay characteristics // Heart Fail Rev. - 2003. - № 8. - Р. 315-320.Azzazy H.M., Christenson R.H. B-type natriuretic peptide: physiologic role and assay characteristics // Heart Fail Rev. - 2003. - № 8. - Р. 315-320.Елисеев О.М. Натрийуретические пептиды. Эволюция знаний // Терапевтический архив. - 2003. - № 9. - С. 40-45.Елисеев О.М. Натрийуретические пептиды. Эволюция знаний // Терапевтический архив. - 2003. - № 9. - С. 40-45.D'Souza S.P., Baxter G.F. B-type natriuretic peptide: a good omen in myocardial ischaemia? // Heart. - 2003. - № 89. - Р. 707-709.D'Souza S.P., Baxter G.F. B-type natriuretic peptide: a good omen in myocardial ischaemia? // Heart. - 2003. - № 89. - Р. 707-709.Schreiber D., Nix D.A. Medscape medical news. Natriuretic peptides in congestive heart failure. http: // www. medscape.com/viewarticle/ 504382. - accessed 8.07.2008.Schreiber D., Nix D.A. Medscape medical news. Natriuretic peptides in congestive heart failure. http: // www. medscape.com/viewarticle/ 504382. - accessed 8.07.2008.Redfield M.M., Rodeheffer R.J., Jacobsen S.J., et al. Plasma brain natriuretic peptide concentration: impact of age and gender // J. Am. Coll. Cardiol. - 2002. - № 40. - Р. 976-982.Redfield M.M., Rodeheffer R.J., Jacobsen S.J., et al. Plasma brain natriuretic peptide concentration: impact of age and gender // J. Am. Coll. Cardiol. - 2002. - № 40. - Р. 976-982.Das S.R., Drazner M.H., Dries D.L., Vega G.L., Stanek H.G., Abdullah S.M., Canham R.M., Chung A.K., Leonard D., Wians F.H., de Lemos J.A. Impact of Body Mass and Body Composition on Circulating Levels of Natriuretic Peptides: Results From the Dallas Heart Study // Circulation. - 2005. - № 112. - Р. 2163-2168.Das S.R., Drazner M.H., Dries D.L., Vega G.L., Stanek H.G., Abdullah S.M., Canham R.M., Chung A.K., Leonard D., Wians F.H., de Lemos J.A. Impact of Body Mass and Body Composition on Circulating Levels of Natriuretic Peptides: Results From the Dallas Heart Study // Circulation. - 2005. - № 112. - Р. 2163-2168.Wang T.J., Larson M.G., Keyes M.J., Levy D., Benjamin E.J., Vasan R.S. Assosiation of plasma natriuretic peptide levels with metabolic risk factors in ambulatory individuals // Circulation. - 2007. - № 115. - Р. 1345-1353.Wang T.J., Larson M.G., Keyes M.J., Levy D., Benjamin E.J., Vasan R.S. Assosiation of plasma natriuretic peptide levels with metabolic risk factors in ambulatory individuals // Circulation. - 2007. - № 115. - Р. 1345-1353.Ellinor P. T., Low A.F., Patton K.K., Shea M.A., Macrae C.A. Discordant atrial natriuretic peptide and brain natriuretic peptide levels in lone atrial fibrillation // J. Am. Coll. Cardiol. - 2005. - № 45(1). - Р. 82-86.Ellinor P. T., Low A.F., Patton K.K., Shea M.A., Macrae C.A. Discordant atrial natriuretic peptide and brain natriuretic peptide levels in lone atrial fibrillation // J. Am. Coll. Cardiol. - 2005. - № 45(1). - Р. 82-86.McKie P. M., Rodeheffer R.J., Cataliotti A., Martin F.L., Urban L.H., Mahoney D.W., Jacobsen S.J., Redfield M.M., Burnett J.C. Amino-Terminal Pro-B-Type Natriuretic Peptide and B-Type Natriuretic Peptide. Biomarkers for Mortality in a Large Community-Based Cohort Free of Heart Failure // Hypertension. - 2006. - № 47(5). - Р. 874-880.McKie P. M., Rodeheffer R.J., Cataliotti A., Martin F.L., Urban L.H., Mahoney D.W., Jacobsen S.J., Redfield M.M., Burnett J.C. Amino-Terminal Pro-B-Type Natriuretic Peptide and B-Type Natriuretic Peptide. Biomarkers for Mortality in a Large Community-Based Cohort Free of Heart Failure // Hypertension. - 2006. - № 47(5). - Р. 874-880.Mueller C., Scholer A., Laule-Kilan K., et al. Use of B-type natriuretic peptide in the evaluation and management of acute dispnea // N. Eng. J. Med. - 2004. - № 350. - Р. 647-654.Mueller C., Scholer A., Laule-Kilan K., et al. Use of B-type natriuretic peptide in the evaluation and management of acute dispnea // N. Eng. J. Med. - 2004. - № 350. - Р. 647-654.Maurellet J.D., Liu P. T. B-type natriuretic peptide in the management of heart failure // Hong Kong Med. J. - 2008. - № 14. - Р. 216-219.Maurellet J.D., Liu P. T. B-type natriuretic peptide in the management of heart failure // Hong Kong Med. J. - 2008. - № 14. - Р. 216-219.Bettencourt P., Azevedo A., Pimenta J. et al. N-terminal pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients // Circulation. - 2004. - № 110. - Р. 2168-2174.Bettencourt P., Azevedo A., Pimenta J. et al. N-terminal pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients // Circulation. - 2004. - № 110. - Р. 2168-2174.Dao Q., Krishnaswamy P., Kazanegra R. et al. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgentcare setting // J. Am. Coll. Cardiol. - 2001. - № 37. - Р. 379-385.Dao Q., Krishnaswamy P., Kazanegra R. et al. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgentcare setting // J. Am. Coll. Cardiol. - 2001. - № 37. - Р. 379-385.Maisel A.S., Krishnaswamy P., Nowak R.M. et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure // N Engl J Med. - 2002. - № 347. - Р. 161-167.Maisel A.S., Krishnaswamy P., Nowak R.M. et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure // N Engl J Med. - 2002. - № 347. - Р. 161-167.Maisel A. Updated algorithms for using B-Type Natriuretic Peptide (BNP) Levels in the Diagnosis and Management of Congestive Heart Failure // Critical Pathways in Cardiology. - 2004. - № 3. - Р. 144-149.Maisel A. Updated algorithms for using B-Type Natriuretic Peptide (BNP) Levels in the Diagnosis and Management of Congestive Heart Failure // Critical Pathways in Cardiology. - 2004. - № 3. - Р. 144-149.Januzzi J.L., Camargo C.A., Anwaruddin S. et al. The N-terminal proBNP investigation of dispnea in the emergency department (PRIDE) study // J. Am. Coll. Cardiol. - 2005. - № 95(8). - Р. 948-954.Januzzi J.L., Camargo C.A., Anwaruddin S. et al. The N-terminal proBNP investigation of dispnea in the emergency department (PRIDE) study // J. Am. Coll. Cardiol. - 2005. - № 95(8). - Р. 948-954.Grewal J., McKelvie R.S., Persson H., Tait P., Carlsson J., Swedberg K., Ostergren J., Lonn E. Usefulness of N-terminal pro-brain natriuretic peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction / Am. J. Cardiol. - 2008. - № 102(6). - Р. 733-737.Grewal J., McKelvie R.S., Persson H., Tait P., Carlsson J., Swedberg K., Ostergren J., Lonn E. Usefulness of N-terminal pro-brain natriuretic peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction / Am. J. Cardiol. - 2008. - № 102(6). - Р. 733-737.Wang T.J., Larson M.G., Levy D., Benjamin E.J., Leip E.P., Omland T., Wolf P. A., Vasan R.S. Plasma natriuretic peptide levels and the risk of cardiovascular events and death // N. Engl. J. Med. - 2004. - № 350. - Р. 655-663.Wang T.J., Larson M.G., Levy D., Benjamin E.J., Leip E.P., Omland T., Wolf P. A., Vasan R.S. Plasma natriuretic peptide levels and the risk of cardiovascular events and death // N. Engl. J. Med. - 2004. - № 350. - Р. 655-663.Park H.S., Kim H., Sohn J.H., Shin H.W., Cho Y.K. et al. Combination of uric acid and NT-proBNP: a more useful prognostic marker for short-term clinical outcomes in patients with acute heart failure // Korean J Intern Med. - 2010. - № 25(3). - Р. 253-259.Park H.S., Kim H., Sohn J.H., Shin H.W., Cho Y.K. et al. Combination of uric acid and NT-proBNP: a more useful prognostic marker for short-term clinical outcomes in patients with acute heart failure // Korean J Intern Med. - 2010. - № 25(3). - Р. 253-259.Lainchbury J.G., Troughton R.W., Strangman K.M., Frampton C.M. et al. N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the Battlescarred (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial // J Am Coll Cardiol. - 2009. - № 55(1). - Р. 53-60.Lainchbury J.G., Troughton R.W., Strangman K.M., Frampton C.M. et al. N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the Battlescarred (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial // J Am Coll Cardiol. - 2009. - № 55(1). - Р. 53-60.De Filippi C.R., Christenon R.H., Gottdiener J.S., Kop W.J., Seliger S.L. Dynamic cardiovascular risk assessment in elderly people: the role of repeated N-terminal pro-B-type natriuretic peptide testing // J Am Coll Cardiol. - 2010. - № 55 (5). - Р. 441-450.De Filippi C.R., Christenon R.H., Gottdiener J.S., Kop W.J., Seliger S.L. Dynamic cardiovascular risk assessment in elderly people: the role of repeated N-terminal pro-B-type natriuretic peptide testing // J Am Coll Cardiol. - 2010. - № 55 (5). - Р. 441-450.Richards M., Nicholls M.G., Esspiner E.A. et al. Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosos in stable ischemic heart disease // J Am Coll Cardiol. - 2006. - № 47(1). - Р. 52-60.Richards M., Nicholls M.G., Esspiner E.A. et al. Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosos in stable ischemic heart disease // J Am Coll Cardiol. - 2006. - № 47(1). - Р. 52-60.Omland T. B-type natriuretic peptides: Prognostic markers in stable coronary artery disease // Expert Rev Mol Diagn. - 2008. - № 8(2). - Р. 217-225.Omland T. B-type natriuretic peptides: Prognostic markers in stable coronary artery disease // Expert Rev Mol Diagn. - 2008. - № 8(2). - Р. 217-225.Magnusson M., Melander O., Israelsson B., Grubb A. et al. Elevated plasma levels of Nt-proBNP in patients with type 2 diabetes without overt cardiovascular disease // Diabetes care. - 2004. - № 27(8). - Р. 1929-1935.Magnusson M., Melander O., Israelsson B., Grubb A. et al. Elevated plasma levels of Nt-proBNP in patients with type 2 diabetes without overt cardiovascular disease // Diabetes care. - 2004. - № 27(8). - Р. 1929-1935.Igarashi М., Jimbu Y., Hirata A., Tominaga M. Characterization of plasma brain natriuretic peptide level in patients with type 2 diabetes // Endocr J. - 2005. - № 52. - Р. 353-362.Igarashi М., Jimbu Y., Hirata A., Tominaga M. Characterization of plasma brain natriuretic peptide level in patients with type 2 diabetes // Endocr J. - 2005. - № 52. - Р. 353-362.Yukawa M., Imanishi K., Oishi C., Shimajiri Y., Futura M., Ueyama M., Sanke T. Clinical usefulness for measurement of plasma brain natriuretic peptide in diabetic patients // Rinsho Byori. - 2007. - № 55(10). - Р. 906-911.Yukawa M., Imanishi K., Oishi C., Shimajiri Y., Futura M., Ueyama M., Sanke T. Clinical usefulness for measurement of plasma brain natriuretic peptide in diabetic patients // Rinsho Byori. - 2007. - № 55(10). - Р. 906-911.Verges B., Zeller M., Desgres J., Dentan G., Laurent Y., Janin-Manificat L., LۥHuiller I., Rioufol G., Beer J.C., Makki H., Rochette L., Gambert P., Cottin Y. High plasma N-terminal pro-brain natriuretic peptide level found in diabetic patients after myocardial infarction is associated with an increased risk of in-hospital mortality and cardiogenic shok // Eur. Heart J. - 2005. - № 26 (17). - Р. 1734-1741.Verges B., Zeller M., Desgres J., Dentan G., Laurent Y., Janin-Manificat L., LۥHuiller I., Rioufol G., Beer J.C., Makki H., Rochette L., Gambert P., Cottin Y. High plasma N-terminal pro-brain natriuretic peptide level found in diabetic patients after myocardial infarction is associated with an increased risk of in-hospital mortality and cardiogenic shok // Eur. Heart J. - 2005. - № 26 (17). - Р. 1734-1741.Gaede P., Hildebrandt P., Hess G., Parving H.H., Pedersen O. Plasma N-terminal pro-brain natriuretic peptides a major risk marker for cardiovascular disease in patients with type 2 diabetes and microalbuminuria // Diabetologia. - 2005. - № 48. - Р. 149-155.Gaede P., Hildebrandt P., Hess G., Parving H.H., Pedersen O. Plasma N-terminal pro-brain natriuretic peptides a major risk marker for cardiovascular disease in patients with type 2 diabetes and microalbuminuria // Diabetologia. - 2005. - № 48. - Р. 149-155.Somaratne J.B., Whalley G.A., Bagg W., Doughty R.N. Early detection and significance of structural cardiovascular abnormalities in patients with type 2 diabetes mellitus // Expert Rev Cardiovasc Ther. - 2008. - № 6. - Р. 109-125.Somaratne J.B., Whalley G.A., Bagg W., Doughty R.N. Early detection and significance of structural cardiovascular abnormalities in patients with type 2 diabetes mellitus // Expert Rev Cardiovasc Ther. - 2008. - № 6. - Р. 109-125.Rana B.S., Davies J.I., Band M.M., Pringle S.D., Morris A., Struthers A.D. B-type natriuretic peptide can detect silent myocardial ischemia in asymptomatic type 2 diabetes // Heart. - 2006. - № 92(7). - Р. 916-920.Rana B.S., Davies J.I., Band M.M., Pringle S.D., Morris A., Struthers A.D. B-type natriuretic peptide can detect silent myocardial ischemia in asymptomatic type 2 diabetes // Heart. - 2006. - № 92(7). - Р. 916-920.Dencker M., Stagmo M., Dorkhan M. Relationship between natriuretic peptides and echocardiography parameters in patients with poorly regulated type 2 diabetes // Vasc Health Risk Manag. - 2010. - № 6. - Р. 373-382.Dencker M., Stagmo M., Dorkhan M. Relationship between natriuretic peptides and echocardiography parameters in patients with poorly regulated type 2 diabetes // Vasc Health Risk Manag. - 2010. - № 6. - Р. 373-382.Andersen N.H., Poulsen S.H., Knudsen S.T., Heickendorff L., Mogensen C.E. NT-proBNP in normoalbuminuric patients with type 2 diabetes mellitus // Diabet. Med. - 2005. - № 22(2). - Р. 188-195.Andersen N.H., Poulsen S.H., Knudsen S.T., Heickendorff L., Mogensen C.E. NT-proBNP in normoalbuminuric patients with type 2 diabetes mellitus // Diabet. Med. - 2005. - № 22(2). - Р. 188-195.

The authors declare that there are no conflicts of interest present.